eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Postmarketing Safety Reporting for Combination Products; Extension of Comment Period

Postmarketing Safety Reporting for Combination Products; Extension of Comment Period

Document ID: FDA-2008-N-0424-0004
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: E9-29493
CFR Citation: 21 CFR 4
View Document:  View as format pdf View as format html

Details Information

Document Subtype: NPR-Notice of Proposed Rule-Making
Received Date: December 11 2009, at 10:53 AM Eastern Standard Time
Start-End Page: 65702 - 65702
Page Count: 1
Comment Start Date: December 11 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: January 29 2010, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 12
Novo Nordisk, Inc. - Comment
Posted: 01/19/2010     ID: FDA-2008-N-0424-0007

Jan 29,2010 11:59 PM ET
PhRMA - Comment
Posted: 01/26/2010     ID: FDA-2008-N-0424-0008

Jan 29,2010 11:59 PM ET
Eli Lilly & Company - Comment
Posted: 01/26/2010     ID: FDA-2008-N-0424-0009

Jan 29,2010 11:59 PM ET
Parenteral Drug Association (PDA) - Comment
Posted: 01/27/2010     ID: FDA-2008-N-0424-0010

Jan 29,2010 11:59 PM ET
sanofi-aventis - Comment
Posted: 01/27/2010     ID: FDA-2008-N-0424-0011

Jan 29,2010 11:59 PM ET

Related Documents

   
Total: 3